http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
USE.com Announce Focus on Exchange Utility as Presale Gains Momentum
-
PEGASUS WORLD CUP CELEBRATES 10 YEARS AS HORSE RACING'S HOTTEST EVENT
-
Plaid With Purpose: Jeep® Wrangler 85th Anniversary Edition Brings Heritage Style to Legendary Capability
-
Societe Generale: Information regarding executed transactions within the framework of a share buy-back programme
-
Nevis to St. Kitts Cross Channel Swim Returns as a Signature Caribbean Endurance Event, Welcoming Olympian Alice Dearing
-
PickleJar Up All Night Launches Across 82 LRN Affiliate Stations, Expanding National Reach and Revenue Opportunities
-
CrowdStrike partners with Nord Security for SMB cybersecurity solutions
-
Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures
-
CrowdStrike and Nord Security Announce Strategic Partnership to Redefine SMB Cybersecurity
-
PPMD Team Member Wins Two Races at 2026 Walt Disney World® Marathon Weekend Presented by State Farm
-
Leading Mental Health Researchers and Advocates to Be Honored at Premier Suicide Prevention Gala on May 7
-
JA Development & Construction Secures Multi-Year Development Partnership in Bastrop, Texas
-
PacBio announces collaboration plans for rare disease therapies
-
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
-
BrightRock Gold Completes FINRA-Approved Name, Ticker and CUSIP Change to North America Lithium and Gold Corp. (NALG)
-
David Ebrahimzadeh and Corniche Capital Advance Power-Enabled Data Center Developments in New Mexico and South Carolina
-
NORWEGIAN CRUISE LINE DEBUTS NEW BRAND PLATFORM, "IT'S DIFFERENT OUT HERE," AND LAUNCHES NATIONAL AD CAMPAIGN
-
Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System
-
Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
-
Miss Florida USA Lou Schieffelin Named Brand Ambassador for Food for the Hungry to Advance Girls’ Education and Women’s Futures
-
HII Expands European Unmanned Operations with New Facility in Portchester, UK
-
MacKay Municipal Managers Shares Top Five Municipal Market Predictions For 2026
-
Clene secures FDA meeting to discuss ALS drug biomarker data
-
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
-
NantWorks and ImmunityBio Announce Inaugural U.S.-Saudi Biotech Alliance Summit to Advance Immunotherapy 2.0 and Global Health Security
-
Water Tower Research Highlights Ainos SmellTech's Rising Commercial Momentum in Scalable AI Infrastructure Platform Shift
-
Cogent Biosciences outlines 2026 milestones for bezuclastinib drug applications
-
Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
-
Praxis plans two drug applications by mid-February, raises $1.5 billion
-
Wealth Minerals announces $1 million private placement offering
-
KOAMTAC Introduces Magnetic Universal Adaptor (MUA) for Fast, Flexible SmartSled Integration
-
MDxHealth reports 21% revenue growth for 2025, issues 2026 guidance
-
Cardiovascular Logistics Appoints Nancy Probst as Vice President of Managed Care
-
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
-
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
-
ZAGG Honored with Consumer Electronics Industry Performance Award from Circana
-
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
-
Ontario International Airport welcomes TSA acceptance of Digital IDs - a smarter, easier way to fly
-
PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
-
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
-
Wealth Minerals Announces Private Placement
-
Bojangles Brings its Iconic Southern Flavors and Fan-Favorite Chicken to New York with Brooklyn Opening
-
Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio
-
EDM Announces Both Completion of 2025 Milestones and Its Operational, Permitting and Commercial Milestones for 2026
-
DeFi Technologies reports record $138M net inflows for Valour in 2025
-
NusaTrip partners with Bookcabin to expand in Indonesia travel market
-
AbbVie licenses cancer drug from RemeGen for $650 million upfront
-
DeFi Technologies Highlights Record Net Inflows at Valour in 2025, Underscoring Core Business Momentum Beyond AUM Price Volatility
-
Kobo Delivers Significant Progress at its Kossou Gold Project in 2025, Establishes a Scalable West African Gold Platform for 2026 and Hosted the 2nd Annual Kobo Cup
-
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
